- Home
- CNTX vs GCTS Comparison
CNTX vs GCTS Comparison
Compare CNTX & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- GCTS
- Stock Information
- Founded
- CNTX 2015
- GCTS 1998
- Country
- CNTX United States
- GCTS United States
- Employees
- CNTX 9
- GCTS N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- GCTS Blank Checks
- Sector
- CNTX Health Care
- GCTS Finance
- Exchange
- CNTX Nasdaq
- GCTS Nasdaq
- Market Cap
- CNTX 78.0M
- GCTS 91.7M
- IPO Year
- CNTX 2021
- GCTS N/A
- Fundamental
- Price
- CNTX $0.78
- GCTS $1.53
- Analyst Decision
- CNTX Strong Buy
- GCTS Strong Buy
- Analyst Count
- CNTX 6
- GCTS 1
- Target Price
- CNTX $6.50
- GCTS $5.00
- AVG Volume (30 Days)
- CNTX 94.4K
- GCTS 186.5K
- Earning Date
- CNTX 05-07-2025
- GCTS 05-14-2025
- Dividend Yield
- CNTX N/A
- GCTS N/A
- EPS Growth
- CNTX N/A
- GCTS N/A
- EPS
- CNTX N/A
- GCTS N/A
- Revenue
- CNTX N/A
- GCTS $9,128,000.00
- Revenue This Year
- CNTX N/A
- GCTS $315.69
- Revenue Next Year
- CNTX N/A
- GCTS $170.56
- P/E Ratio
- CNTX N/A
- GCTS N/A
- Revenue Growth
- CNTX N/A
- GCTS N/A
- 52 Week Low
- CNTX $0.55
- GCTS $1.16
- 52 Week High
- CNTX $2.75
- GCTS $6.32
- Technical
- Relative Strength Index (RSI)
- CNTX 45.08
- GCTS 53.34
- Support Level
- CNTX $0.74
- GCTS $1.38
- Resistance Level
- CNTX $0.85
- GCTS $1.44
- Average True Range (ATR)
- CNTX 0.09
- GCTS 0.06
- MACD
- CNTX -0.02
- GCTS 0.03
- Stochastic Oscillator
- CNTX 13.67
- GCTS 85.29
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.